Thymosin Alpha – 1 (Tα1), a synthetic polypeptide composed of 28 amino acids, has a molecular formula of (C_{129}H_{215}N_{43}O_{37}S) and a molecular weight of approximately 3108.4 Da. Presented as a white to off – white lyophilized powder, it exhibits excellent stability under appropriate storage conditions, typically remaining viable for extended periods when stored at low temperatures.
Discovered in the 1970s during research on thymic hormones, Tα1 was initially isolated from the thymus gland. However, due to the limited natural sources and complex extraction process, synthetic methods were developed, making it more accessible for research and medical applications.
The primary function of Tα1 lies in its powerful immunomodulatory properties. It acts as a key regulator of the immune system by stimulating the maturation and activation of T – lymphocytes, especially helper T – cells and cytotoxic T – cells. This activation triggers a cascade of immune responses, including the enhanced production of cytokines such as interferon – gamma and interleukin – 2. These cytokines play crucial roles in coordinating the body’s adaptive immune response, enabling it to more effectively combat various pathogens, including viruses, bacteria, and fungi. For instance, in the treatment of chronic viral infections like hepatitis B, Tα1 has been shown to enhance the body’s ability to suppress viral replication by boosting the activity of immune cells.
Moreover, Tα1 demonstrates anti – inflammatory effects. It can modulate the production of pro – inflammatory cytokines, reducing excessive inflammation that can lead to tissue damage. Additionally, it promotes the repair of damaged immune cells, contributing to the overall restoration of immune function.
In the medical field, Tα1 has been widely studied and applied. It has shown promise in treating a variety of diseases, including chronic hepatitis B, AIDS – related complications, and certain types of cancer. In cancer therapy, Tα1 is often used in combination with chemotherapy. It not only enhances the anti – tumor efficacy of chemotherapy drugs but also helps to reduce the side effects associated with chemotherapy by strengthening the immune system.
Furthermore, Tα1 has potential applications in vaccine adjuvants, improving the immune response to vaccines and enhancing their effectiveness.
In research, Tα1 serves as a valuable tool for studying immune – related mechanisms and developing new immunotherapies. As our understanding of its functions continues to grow, the potential applications of Thymosin Alpha – 1 are expected to expand, offering new hope for the treatment of various immune – mediated and infectious diseases.
Beijing Qiangtai BioTech Co., Ltd. is a pioneering force in the biotechnology sector.
At the core of our operations is the unwavering commitment to our guiding principles : “Quality First, Service Supreme.”Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.
Our primary focus encompasses a range of products , including weight loss peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Tirzepatide, Retatrutide, and others.Provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the Clients.We have professional sales team , focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market, our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.
With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers .
Reviews
There are no reviews yet.